ADENOVIRUS FORMULATIONS
Application
US20260083670A1
Kind: A1
Mar 26, 2026
Inventors
Tao PENG, Yuan Hao Lucas GOH
Abstract
An improved adenovirus formulation comprising: a) a recombinant adenovirus; b) a citrate buffer; c) a cyclodextrin compound; and d) a salt, said formulation having a pH ranging from about 5.5 to about 6.5, and wherein said formulation is free of non-ionic detergent. The invention also relates to a method of preserving an adenovirus which comprises preparing said formulation.
CPC Classifications
A61K 9/08
A61K 9/0019
A61K 35/761
A61K 47/02
A61K 47/10
A61K 47/12
A61K 47/40
C12N 2710/10343
Filing Date
2023-09-11
Application No.
19111190